334 related articles for article (PubMed ID: 19694967)
1. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.
Schreurs M; Kuipers F; van der Leij FR
Obes Rev; 2010 May; 11(5):380-8. PubMed ID: 19694967
[TBL] [Abstract][Full Text] [Related]
2. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
3. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
4. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.
Harwood HJ
Curr Opin Investig Drugs; 2004 Mar; 5(3):283-9. PubMed ID: 15083594
[TBL] [Abstract][Full Text] [Related]
7. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart.
Lopaschuk GD; Witters LA; Itoi T; Barr R; Barr A
J Biol Chem; 1994 Oct; 269(41):25871-8. PubMed ID: 7929291
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway.
Waring JF; Yang Y; Healan-Greenberg CH; Adler AL; Dickinson R; McNally T; Wang X; Weitzberg M; Xu X; Lisowski A; Warder SE; Gu YG; Zinker BA; Blomme EA; Camp HS
J Pharmacol Exp Ther; 2008 Feb; 324(2):507-16. PubMed ID: 18025247
[TBL] [Abstract][Full Text] [Related]
10. The liver isoform of carnitine palmitoyltransferase 1 is not targeted to the endoplasmic reticulum.
Broadway NM; Pease RJ; Birdsey G; Shayeghi M; Turner NA; David Saggerson E
Biochem J; 2003 Feb; 370(Pt 1):223-31. PubMed ID: 12401113
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.
Yoon MJ; Lee GY; Chung JJ; Ahn YH; Hong SH; Kim JB
Diabetes; 2006 Sep; 55(9):2562-70. PubMed ID: 16936205
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
[TBL] [Abstract][Full Text] [Related]
13. Induction of carnitine palmitoyl transferase 1 and fatty acid oxidation by retinoic acid in HepG2 cells.
Amengual J; Petrov P; Bonet ML; Ribot J; Palou A
Int J Biochem Cell Biol; 2012 Nov; 44(11):2019-27. PubMed ID: 22871568
[TBL] [Abstract][Full Text] [Related]
14. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
15. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
[TBL] [Abstract][Full Text] [Related]
16. Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression.
Vega VA; Anzulovich AC; Varas SM; Bonomi MR; Giménez MS; Oliveros LB
Nutrition; 2009; 25(7-8):828-38. PubMed ID: 19342198
[TBL] [Abstract][Full Text] [Related]
17. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
Gao X; Li K; Hui X; Kong X; Sweeney G; Wang Y; Xu A; Teng M; Liu P; Wu D
Biochem J; 2011 May; 435(3):723-32. PubMed ID: 21348853
[TBL] [Abstract][Full Text] [Related]
18. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Thupari JN; Pinn ML; Kuhajda FP
Biochem Biophys Res Commun; 2001 Jul; 285(2):217-23. PubMed ID: 11444828
[TBL] [Abstract][Full Text] [Related]
20. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats.
Morifuji M; Sanbongi C; Sugiura K
Br J Nutr; 2006 Sep; 96(3):469-75. PubMed ID: 16925851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
